Navigation Links
Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments
Date:8/3/2009

atory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for weight management. Arena has a broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, which includes compounds being evaluated independently and with partners, including Merck & Co., Inc., and Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Development.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about future activities, results and announcements relating to lorcaserin, including the BLOSSOM results, the submission of a lorcaserin NDA, the content of such NDA, and the submission of the BLOOM-DM results as a supplement to the NDA; the development, advancement, therapeutic indication, tolerability, safety, selectivity and efficacy of lorcaserin; the protocol, design, scope, enrollment and other aspects of the lorcaserin trials; the potential of lorcaserin in managing weight, improving health and generating commercial and other interest; Arena's financial position and its impact on Arena's abilities; the approval of lorcaserin for marketing; partnering discussions; financial guidance; the decline of Arena's research and development expenses; cost savings from Arena's reduction in force and other cost-containment efforts; dosing in lorcaserin clinical trials expected to be included in the planned NDA submission; Arena's agreements with Azimuth and Deerfield and rights and future activities thereunder; and Arena's strategy, internal and partnered programs, and ability to develop compounds and commercialize drugs. For such
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Arena Pharmaceuticals Announces Public Offering of Common Stock
3. Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
4. Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
6. Arena Pharmaceuticals Lorcaserin for Obesity Passes Major Safety Milestone
7. Arena Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
8. Arena Pharmaceuticals to Report First Quarter 2008 Financial Results and to Host Conference Call and Webcast on Wednesday, May 7, 2008
9. Field Poll: California Nurses Association Most Favorably Viewed Group in Healthcare Arena
10. Childrens Miracle Network and Arena Football League Partner for First Nationwide Celebration Event
11. Arena Pharmaceuticals Announces Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2014)... NY (PRWEB) July 26, 2014 As ... magazine on July 23rd, new research by Palo Alto ... to rewrite their playbook, now focusing more on businesses ... masse who have become increasingly wise to their tactics ... founder and CEO/CTO, Joe Caruso, talks about the evolution ...
(Date:7/26/2014)... According to the Tinnitus ... this is a comprehensive guide that consists ... all types of disorders related to ... due to Ménière's disease ,     Objective ... tinnitus ,     Inner, middle or external ...
(Date:7/26/2014)... (PRWEB) July 26, 2014 “Healthy teeth are ... keeping those pearly whites shining,” says Community Health Center of ... Healthy ." , They believe that an integration of medical ... healthy and well. Because of this, they encourage regular cleanings ... with dentist . , “Children and adults will find ...
(Date:7/26/2014)... New York (PRWEB) July 26, 2014 ... to be filed in U.S. courts, Bernstein Liebhard LLP ... federal health regulators to ban uterine morcellation. According to ... a 46-year-old mother of four from California who was ... cancer called leiomyosarcoma just 10 days after undergoing a ...
(Date:7/26/2014)... Multiple sclerosis (MS), also known ... inflammatory disease in which the insulating covers of ... are damaged. This damage disrupts the ability of ... in a wide range of signs and symptoms, ... sclerosis takes several forms, with new symptoms either ...
Breaking Medicine News(10 mins):Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 2Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 3Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 4Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 5Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 6Health News:Tinnitus Miracle Book Review Exposes Thomas Coleman's Guide for Treating Tinnitus – Vkool.com 2Health News:Common Dental Care Questions Answered by Community Health Center of Snohomish County in Recent Article 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes New Calls for Ban on Uterine Mocellation In Light of Cancer Risk 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes New Calls for Ban on Uterine Mocellation In Light of Cancer Risk 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes New Calls for Ban on Uterine Mocellation In Light of Cancer Risk 4Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 2Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 3Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 4
... the journal Clinical Cardiology reveals that a Super Bowl ... in both men and women and in older individuals. , Sports ... the team loses, it can cause some degree of emotional stress. ... Institute, Good Samarian Hospital and Keck School of Medicine at USC ...
... real estate developer Douglas Rosenberg says he has a new ... Through the Ellen and Douglas Rosenberg Foundation, the venture philanthropist ... Bredesen, MD has the correct take on how to thwart ... The two have formed a unique partnership aimed at developing ...
... 29 (HealthDay News) -- Dry eye syndrome is common in ... heat, says an eye expert. Symptoms include pain, blurred ... as the eyes try to compensate for the dryness, explains ... and allergies can cause watery eyes, differentiating the two conditions ...
... Randy Dotinga HealthDay Reporter , FRIDAY, Jan. 28 ... percent of patients are considered difficult, and they,re more likely ... of the equation: Researchers also report that older doctors and ... patients. "The patients who have these kinds of problems ...
... that appears to contribute to blood vessel damage in ... Washington University School of Medicine in St. Louis. ... of the nearly 26 million Americans with the disease ... vision loss because of damaged vessels. Reporting in ...
... stress management techniques before prostate cancer surgery may help ... as well as aid in lowering mood disturbance, according ... of Texas MD Anderson Cancer Center. The ... journal Psychosomatic Medicine . It,s the first to ...
Cached Medicine News:Health News:Philanthropist invests $3.5 million in Buck Institute's Alzheimer's drug development effort 2Health News:Philanthropist invests $3.5 million in Buck Institute's Alzheimer's drug development effort 3Health News:Philanthropist invests $3.5 million in Buck Institute's Alzheimer's drug development effort 4Health News:Dry Eye Syndrome Common in Winter 2Health News:Docs Rate Almost 1 in 5 Patients as 'Difficult': Study 2Health News:Researchers discover root cause of blood vessel damage in diabetes 2Health News:Researchers discover root cause of blood vessel damage in diabetes 3Health News:Researchers discover root cause of blood vessel damage in diabetes 4Health News:Pre-surgical stress management boosts immune function, lowers mood disturbance in prostate cancer patients 2Health News:Pre-surgical stress management boosts immune function, lowers mood disturbance in prostate cancer patients 3
(Date:7/25/2014)... 25, 2014  Corporate libraries are constantly being faced ... in technology and how to cope with flat or ... pharmaceutical and medical device industries are increasingly finding it ... services they provide. According to recent ... many forces of change that leading corporate libraries are ...
(Date:7/25/2014)... CHAPEL HILL, N.C. , July 25, 2014 /PRNewswire/ ... therapeutic area is costly and challenging - as is ... area. Is it possible - or ... products together? If so, where can you combine resources ... remain separated? These are just a ...
(Date:7/25/2014)... /PRNewswire-iReach/ -- "Australia Capsule Endoscopy Systems Market Outlook to ... Endoscopy Systems market. The report provides value, in millions ... (in US dollars) within market segments: Photo ... Endoscopes , Capsule Endoscopy Data Recorders , ... provides company shares and distribution shares data for each ...
Breaking Medicine Technology:Forces of Change Reshaping Corporate Libraries & Information Services 2Using Promotional Efficiency to Support Multiple Products and Indications in the Pharmaceutical Marketplace 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 3Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 4Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 5
... FRANCISCO, Jan. 29 Inverseon, Inc.,( http://www.inverseon.com ) ... trial in asthma., In the article by ... 21, (2008), pp. 134-141, entitled, "The safety and,effects ... open-label pilot,study," mild asthmatics were treated for 9 ...
... New Patient Data Posted Online Shows Improvements Across ... The Cystic Fibrosis,Foundation reported today that key indicators ... lung function and nutritional status -- are,rising nationwide ... fact, the outlook for people with CF continues ...
Cached Medicine Technology:Inverseon Announces Positive Phase IIa Asthma Study 2Cystic Fibrosis Foundation Reports Upward Trend for Key Health Outcomes 2
... when people are in need of MRI ... the tunnel-type scanners. They have heard of, ... highly claustrophobic and noisy tubes of supercon ... them. What people want is a patient-friendly ...
... spectrofluorometer is the ... among the FLUORAT®-02 ... intended for scientific ... and for operation ...
The Spex SkinSkan is the only in-vivo, fibre-optic spectrofluorometer designed specifically for skin-fluorescence measurements. It is also ideal for many remote sensing steady-state fluorescence appl...
... The BTF-111 miniature ... a user-con?gured spectrometer for ... nm. Con?gurable excitation light ... ?exibility of 2D ?uorescence ...
Medicine Products: